Higher Thinking Brain Cancer Research Fund

Gliomas are brain tumours that develop from astrocyte/glial brain cells. There are many different kinds of brain tumours and so the World Health Organisation has broadly categorised them as being low grade (slower growing) or high grade (faster growing). If left untreated, low-grade gliomas will progress to become a high-grade glioma and so patients will undergo a combination of chemotherapy, radiation therapy and surgery to treat the glioma.

 

Given that the tumour has the ability to return after treatment, the long-term prognosis for patients has not improved greatly over the last 30 years. As such, medical research is particularly important to advance knowledge and understanding of the disease.

 

Established in 2011 by Shalom Andrews and her husband Dave Taylor, the Higher Thinking Fund supports medical research into low grade tumours.

Donation Information
$ 50.00
$ 100.00
$ 250.00
$ 500.00
$    
Additional Information
Type of gift:
Billing Information
*
*
*
*
*
*
*
*
*
Payment Information
*
*
  *
*
help *
Additional Security
This is a security measure to help prevent fraud.

 

PRIVACY NOTICE: Information contained in this form will be used for the purpose of processing your gift and for directly related purposes such as audit, management and operational activities of UNSW Philanthropy. Unless you have requested this gift to be anonymous, UNSW may disclose your name and gift information to the Higher Thinking Fund fundraising team. Provision of this information is voluntary. You can submit a request for access to or amendment of your personal information by contacting giving@unsw.edu.au. We handle your personal information in accordance with the UNSW Privacy Management Plan.

As one of the leading medical schools internationally, UNSW Medicine & Health spans nine clinical schools, a collaboration of medical research institutes and close affiliation with Australia’s finest hospitals and healthcare providers.

Our community of cancer researchers span laboratory sciences, clinical practice, and health policy; specifically, to translate research into outcomes for patients and communities.

In partnership with the Higher Thinking Fund, we are enabling our best and brightest cancer researchers. Against the backdrop of increasingly competitive levels of public funding, support from the Higher Thinking Fund allows our cancer researchers to work uninterrupted to advance knowledge and understanding of gliomas.

We are only beginning to unlock the potential to bring new interventions and treatment for patients living with brain tumours. With your support, we may generate the knowledge necessary to translate discoveries into improved outcomes for patients and their families.

 

For further information please contact:
Abel Orellana
Development Manager, UNSW Medicine & Health
E: a.orellana@unsw.edu.au
T: 0422 488 480